Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CStone Pharmaceuticals Director's Dealing 2022

Sep 6, 2022

50715_rns_2022-09-06_9a601696-c1af-47fb-8cb1-e50c25cac4f4.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [173 x 58] intentionally omitted <==

Public Disclosure Form

6 September 2022

Possible offer

Disclosure of dealings in the shares of Yankuang Energy Group Company Limited

The Executive received the following disclosure of securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers:

Party Date Descriptionof relevantsecurities Nature of dealings Purchase /Sale Totalnumberof sharesinvolved Total amountpaid / received Highest (H)prices paid/ received Lowest (L)prices paid/ received
ChinaInternationalCapitalCorporationLimited 5 September2022 Ordinaryshares Hedging as a result of the creationof new index-tracking ETFs wherethe relevant securities representless than 1% of the class in issueand less than 20% of the value ofthe securities in the basket orindex Purchase 400 $21,458.0000 $53.6450 $53.6450

Public Disclosure Form

==> picture [71 x 43] intentionally omitted <==

Ordinary Disposal of the underlying shares Sale 10,500 $565,594.0000 $54.1600 $53.6129
shares received from the redemption of
pre-existing index-tracking ETFs
as a result of unsolicited client
requests

End

Note:

China International Capital Corporation Limited is an exempt principal trader connected with the Offeror. Dealings were made for its own account.

The shares reported refer to A shares of Yankuang Energy Group Company Limited (600188.SH), and price per unit is in RMB.